TP53 and cancer: Some of the intracellular PDT resistance mechanisms identified are similar for other treatments, and are associated with: changes in expression of proteins related to cell death, like P53; constitutive activation of Wnt/β-catenin pathway; epithelial to mesenchymal transition (EMT); or presence of cancer stem cells12–14.